Patents by Inventor Gregory M. Preston

Gregory M. Preston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11921975
    Abstract: An application launching user interface that includes a plurality of application icons for launching corresponding applications is displayed. A first touch input is detected on a first application icon of the plurality of application icons. The first application icon is for launching a first application that is associated with one or more corresponding quick actions. If the first touch input meets one or more application-launch criteria which require that the first touch input has ended without having met a first input threshold, the first application is launched in response to the first touch input. If the first touch input meets one or more quick-action-display criteria which require that the first touch input meets the first input threshold, one or more quick action objects associated with the first application are concurrently displayed along with the first application icon without launching the first application, in response to the first touch input.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: March 5, 2024
    Assignee: APPLE INC.
    Inventors: Jonathan R. Dascola, Marcos Alonso Ruiz, Chanaka G. Karunamuni, Stephen O. Lemay, Gregory M. Apodaca, Nicholas V. King, Daniel T. Preston
  • Patent number: 6300075
    Abstract: Disclosed herein are improved methods for amplifying nucleic acids. The methods encompass a method for increasing the specificity of amplification of a target nucleic acid in an amplification reaction, where the reaction reagents include one or more oligonucleotide amplification primers specific to the target nucleic acid, a target nucleic acid, a nucleic acid polymerase, and one or more magnesium salts, by preparing a primer/carrier mixture comprising one or more oligonucleotide amplification primers and carrier nucleic acid, and contacting the primer/carrier admixture with target nucleic acid, one or more magnesium salts, and nucleic acid polymerase.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: October 9, 2001
    Assignee: Ortho-Clinical Diagnostics, INC
    Inventors: Gregory M. Preston, John W. Backus